Accéder au contenu
Merck

Synergistic antibacterial effect of silver and ebselen against multidrug-resistant Gram-negative bacterial infections.

EMBO molecular medicine (2017-06-14)
Lili Zou, Jun Lu, Jun Wang, Xiaoyuan Ren, Lanlan Zhang, Yu Gao, Martin E Rottenberg, Arne Holmgren
RÉSUMÉ

Multidrug-resistant (MDR) Gram-negative bacteria account for a majority of fatal infections, and development of new antibiotic principles and drugs is therefore of outstanding importance. Here, we report that five most clinically difficult-to-treat MDR Gram-negative bacteria are highly sensitive to a synergistic combination of silver and ebselen. In contrast, silver has no synergistic toxicity with ebselen on mammalian cells. The silver and ebselen combination causes a rapid depletion of glutathione and inhibition of the thioredoxin system in bacteria. Silver ions were identified as strong inhibitors of

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Ebselen, cysteine modifier